Pathological complete response following docetaxel-based neoadjuvant chemotherapy for locally advanced gastric
C Bueno Muiño1, J Puente Vázquez, J Sastre Valera
1Servicio de Oncología Médica, Hospital Clínico San Carlos, Madrid, Spain. corabumu@hotmail.com
Abstract:
Locally advanced gastric adenocarcinoma has a poor outcome. Neoadjuvant treatment is being tested in locally advanced non-resectable tumours and in those resectable tumours with a high risk of recurrence. Efforts to identify prognostic factors and more active and less toxic preoperative regimens are being searched for. We report the case of a patient achieving a complete histopathological complete response following docetaxel- based neoadjuvant chemotherapy.
